Vertex Pharmaceuticals secured European approval for Alyftrek, reinforcing its dominance in cystic fibrosis treatment as ...

Curve Finance is warning users that its domain name system might have been hijacked, only a week after its X handle was taken over.

The FDA has approved the expanded use of Trikafta for the treatment of cystic fibrosis in patients aged 2 years and older.

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAF ...

BOSTON, December 20, 2024--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has approved the expanded use of TRIKAFTA® (elexacaftor ...

The Saskatchewan government has announced it is increasing coverage for a drug used to treat cystic fibrosis. Patients and doctors say that's great news.

New report finds that Trikafta patients’ admissions to hospital fell by an average of 65 per cent over one year – but at a list price of over $300,000, the drug is not yet considered cost ...

Trikafta, which was registered in the United States in 2019, has been hailed as a "miracle" treatment for cystic fibrosis, which causes severe damage to the lungs, digestive system and other organs in ...

From a young age, Emily Naismith watched her peers die from cystic fibrosis. The drug Trikafta gave her a future but she says forming a new identity has been complex.

Doctors started to see hints that Trikafta in utero could help babies with CF too. Of the hundreds of children born to mothers on Trikafta, only a few of the babies had CF themselves.